(Hypertension. 2000;36:187.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
CA-Repeat Polymorphism in Intron 1 of HSD11B2
Effects on Gene Expression and Salt Sensitivity
From the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Tex (A.K.A., H.N., P.C.W.); the Division of Endocrinology, University of Ancona, Ancona, Italy (G.G., F.M.); the Division of Medical Sciences, University of Birmingham Queen Elizabeth Hospital, Birmingham, UK (G.L., M.R., C.McT., P.M.S.); Instituto di Ematologia e di Endocrinologia, Universita degli studi Sassari, Sassari, Italy (M.P.); the Division of Nephrology, Dialysis and Hypertension, University of Milan, S Raffaele Hospital, Milan, Italy (G.B., P.M.); and the Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Naples, Italy (P.S.).
Correspondence to Perrin C. White, MD, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9063. E-mail pwhit2{at}mednet.swmed.edu
Abstract—Mutations in the HSD11B2 gene encoding the kidney (11-HSD2) isozyme of 11ß-hydroxysteroid dehydrogenase cause apparent mineralocorticoid excess, a form of familial hypertension. Because the hypertension associated with AME is of the salt-sensitive type, it seemed possible that decreases in 11-HSD2 activity might be associated with salt sensitivity. To examine this, Italians with mild hypertension underwent a protocol consisting of a rapid intravenous saline infusion and subsequent furosemide diuresis. To determine whether there were genetic associations between HSD11B2 and salt sensitivity, 198 Italians were genotyped for a CA repeat polymorphism (11 alleles) in the first intron. Increased differences in mean arterial pressure between the sodium loaded and depleted states were correlated with shorter CA repeat length (R=0.214, P=0.0025). The effect behaved as a recessive trait. This suggested that decreased HSD11B2 expression was associated with shorter CA repeat length. Furthermore, activity of renal 11-HSD2 as measured by an increase in the ratio of urinary-free cortisol/urinary-free cortisone was lower in 33 salt-sensitive subjects (urinary-free cortisol/urinary-free cortisone 0.89±0.04 [mean±SE]) compared with 34 salt-resistant subjects (0.71±0.04, P<0.001). However, when minigenes containing either 14 or 23 CA repeats were transfected into rabbit or human kidney cortical collecting duct cells, the construct with 14 repeats was instead expressed at levels 50% higher than those of the construct with 23 repeats, as determined by reverse transcription–polymerase chain reaction. We conclude that polymorphisms in HSD11B2 and decreased 11-HSD2 activity are associated with sensitivity to sodium loading, but a functional explanation for these associations remains to be elucidated.
Key Words: polymorphism • gene expression • hypertension, genetic • dehydrogenases • dinucleotide repeat
This article has been cited by other articles:
 |
|
 |
|
  Y. Liu, D. Mladinov, J. L. Pietrusz, K. Usa, and M. Liang Glucocorticoid response elements and 11{beta}-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression Cardiovasc Res, January 1, 2009; 81(1): 140 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Dwyer, L Blizzard, B Patterson, A-L Ponsonby, K Martin, S Quinn, M M Sale, S M Richards, R Morley, S Rich, et al. Association between birth weight and adolescent systolic blood pressure in a caucasian birth cohort differs according to skin type, CRH promoter or 11{beta}-HSD2 genotype Arch. Dis. Child., September 1, 2008; 93(9): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis Rheumatology, January 1, 2008; 47(1): 72 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Alikhani-Koupaei, F. Fouladkou, P. Fustier, B. Cenni, A. M. Sharma, H.-C. Deter, B. M. Frey, and F. J. Frey Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity FASEB J, November 1, 2007; 21(13): 3618 - 3628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Sharma, N. Kumar, S. K. Brahmachari, and S. Ramachandran Abundance of dinucleotide repeats and gene expression are inversely correlated: a role for gene function in addition to intron length Physiol Genomics, September 11, 2007; 31(1): 96 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Morineau, V. Sulmont, R. Salomon, B. Fiquet-Kempf, X. Jeunemaitre, J. Nicod, and P. Ferrari Apparent Mineralocorticoid Excess: Report of Six New Cases and Extensive Personal Experience J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3176 - 3184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quinkler, D. Zehnder, J. Lepenies, M. D Petrelli, J. S Moore, S. V Hughes, P. Cockwell, M. Hewison, and P. M Stewart Expression of renal 11{beta}-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function Eur. J. Endocrinol., August 1, 2005; 153(2): 291 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Draper and P. M Stewart 11{beta}-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action J. Endocrinol., August 1, 2005; 186(2): 251 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Kostek, M. J. Delmonico, J. B. Reichel, S. M. Roth, L. Douglass, R. E. Ferrell, and B. F. Hurley Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults J Appl Physiol, June 1, 2005; 98(6): 2147 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Yao, R. C. Harris, and M.-Z. Zhang Interactions between 11{beta}-hydroxysteroid dehydrogenase and COX-2 in kidney Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1767 - R1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Glorioso, F. Filigheddu, P. P. Parpaglia, A. Soro, C. Troffa, G. Argiolas, and P. Mulatero 11{beta}-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension Eur. Heart J., March 1, 2005; 26(5): 498 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Lee, M.-H. Jeon, Y.-J. Seo, Y.-J. Lee, J. H. Ko, Y. Tsujimoto, and J.-H. Lee CA Repeats in the 3'-Untranslated Region of bcl-2 mRNA Mediate Constitutive Decay of bcl-2 mRNA J. Biol. Chem., October 8, 2004; 279(41): 42758 - 42764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bocchi, S. Kenouch, M. Lamarre-Cliche, M. Muffat-Joly, M. H. Capron, J. Fiet, G. Morineau, M. Azizi, J. P. Bonvalet, and N. Farman Impaired 11-{beta} Hydroxysteroid Dehydrogenase Type 2 Activity in Sweat Gland Ducts in Human Essential Hypertension Hypertension, April 1, 2004; 43(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Lavery, V. Ronconi, N. Draper, E. H. Rabbitt, V. Lyons, K. E. Chapman, E. A. Walker, C. L. McTernan, G. Giacchetti, F. Mantero, et al. Late-Onset Apparent Mineralocorticoid Excess Caused by Novel Compound Heterozygous Mutations in the HSD11B2 Gene Hypertension, August 1, 2003; 42(2): 123 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Qin, A. E. Rudolph, B. R. Bond, R. Rocha, E. A.G. Blomme, J. J. Goellner, J. W. Funder, and E. G. McMahon Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure Circ. Res., July 11, 2003; 93(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quinkler and P. M. Stewart Hypertension and the Cortisol-Cortisone Shuttle J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2384 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Draper, S. M. Echwald, G. G. Lavery, E. A. Walker, R. Fraser, E. Davies, T. I. A. Sorensen, A. Astrup, J. Adamski, M. Hewison, et al. Association Studies between Microsatellite Markers within the Gene Encoding Human 11{beta}-Hydroxysteroid Dehydrogenase Type 1 and Body Mass Index, Waist to Hip Ratio, and Glucocorticoid Metabolism J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4984 - 4990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Nawrocki, C. E. Goldring, R. M. Kostadinova, F. J. Frey, and B. M. Frey In Vivo Footprinting of the Human 11beta -Hydroxysteroid Dehydrogenase Type 2 Promoter. EVIDENCE FOR CELL-SPECIFIC REGULATION BY Sp1 AND Sp3 J. Biol. Chem., April 19, 2002; 277(17): 14647 - 14656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ferrari, A. Sansonnens, B. Dick, and F. J. Frey In Vivo 11{beta}-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice Hypertension, December 1, 2001; 38(6): 1330 - 1336. [Abstract] [Full Text] [PDF]
|
|